The company's value-driven, streamlined laboratory processes support reliable and informative scientific study designs, ensuring high-quality results. Its laboratory in Kansas City, KS, boasts a ...

“This event comes on the heels of regulatory agencies and industry innovators accelerating the push to utilize scientifically validated NAMs, which aim to provide more human-relevant preclinical drug ...

WOODBURY, N.Y.--(BUSINESS WIRE)--BioIVT, the leading biospecimen solutions provider and global research partner for drug and diagnostic development, today announced its presence at the 65 th Annual ...

Accelerator Mass Spectrometry (AMS) is having a massive impact on how human ADME studies are conducted, bringing new levels of sensitivity, efficiency, and data quality to pharmacokinetic research. In ...

DUBLIN--(BUSINESS WIRE)--The "ADME-Toxicology Testing: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. Global ADME-Toxicology Testing Market to Reach ...

It may sound harsh, but drug candidates that are bound to be poor performers should be identified sooner rather than later—and ruthlessly eliminated from development. Granted, early in development, ...

Predictive toxicology tools and safety strategies put in place earlier in the drug-development process will begin to deliver in the future, according to Stephane Dhalluin, Ph.D., director of ...

ANTWERP, BELGIUM, February 16, 2026 /EINPresswire.com/ — SGS today announced it has received formal approval from the Belgian Federal Agency for Nuclear Control ...

Company will present at the 65th Annual SOT Meeting and host an in-person symposium & virtual discussion panel focused on New Approach Methodologies (NAMs) At SOT 2026, BioIVT experts, leaders, and ...